Fingolimod Completed Phase 3 Trials for Relapsing Remitting Multiple Sclerosis (RRMS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00289978Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis